Search

Carers’ wellbeing, confidence and health are at the heart of the new National Carers Strategy. For carers in Ireland, this means recognition and acknowledgement of their role as key care partners.

For a number of years we have mentioned the possibility of a new drug called Alemtuzumab being a potential new treatment for people with MS. On 12 June 2012 the makers, Genzyme, announced that the company has made an official application to the Food and Drugs Administration (FDA) in the US and the European Medicines Agency (EMA).

The wonderful people over at shift.ms have created this fantastic video – watch here.

The Neurological Alliance of Ireland, the umbrella group for neurological charities, have launched an online survey to ask people with neurological conditions about their access to rehabilitation services

Drum roll...

Balancing work while living with MS                                               

An Australian CCSVI clinical trial is soon to start

Approaches to Migraine Management

In the HSE Performance report published June 2012, neurology is one of six specialities accounting for high numbers of patients waiting longer than 12 months for an OPD appointment.